Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 26, 2021International Journal of Molecular SciencesOpen Access

Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

HYHidekatsu YanaiNational Center for Global Health and MedicineHAHiroki AdachiNational Center for Global Health and MedicineMHMariko HakoshimaNational Center for Global Health and Medicine

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yanai et al. (2021) studied this question.

synapsesocial.com/papers/6968058bfc4233ff0532ba32https://doi.org/10.3390/ijms22179221
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effects of febuxostat on platelet-derived microparticles and adiponectin in patients with hyperuricema2015 · 20 citations
  2. 2Association between serum uric acid levels and dyslipidemia in Chinese adults2020 · 38 citations
  3. 3Losartan treatment for hypertensive patients with hyperuricaemia in Chinese population2015 · 23 citations
  4. 4Recent advances on uric acid transporters2017 · 183 citations
  5. 5Uric acid and the cardio‐renal effects of SGLT2 inhibitors2019 · 183 citations